61Cu-NODAGA-PSMA
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for 61Cu-NODAGA-PSMA, covering 2024-12-16 to 2024-12-16. Get the full timeline:
Most recent: Clinical Trial Update: A Phase I Trial of 61Cu-NODAGA-PSMA for Patients with Prostate Cancer [Phase 1]